{"pmid":32485243,"title":"Letter to the editor: Awake Craniotomy for Intracranial Gliomas during COVID-19 Pandemic.","text":["Letter to the editor: Awake Craniotomy for Intracranial Gliomas during COVID-19 Pandemic.","World Neurosurg","Nunez-Velasco, Santiago","Mercado-Pimentel, Rodrigo","Rodriguez-Arias, Regina","32485243"],"journal":"World Neurosurg","authors":["Nunez-Velasco, Santiago","Mercado-Pimentel, Rodrigo","Rodriguez-Arias, Regina"],"date":"2020-06-03T11:00:00Z","year":2020,"_id":"32485243","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.wneu.2020.05.219","keywords":["awake craniotomy","covid-19","glioma","neurosurgery","sars-cov-2"],"topics":["Prevention"],"weight":1,"_version_":1668532114843238400,"score":9.490897,"similar":[{"pmid":32274630,"pmcid":"PMC7145274","title":"Inpatient and outpatient case prioritization for patients with neuro-oncologic disease amid the COVID-19 pandemic: general guidance for neuro-oncology practitioners from the AANS/CNS Tumor Section and Society for Neuro-Oncology.","text":["Inpatient and outpatient case prioritization for patients with neuro-oncologic disease amid the COVID-19 pandemic: general guidance for neuro-oncology practitioners from the AANS/CNS Tumor Section and Society for Neuro-Oncology.","The Coronavirus pandemic has created unprecedented strain on medical resources at health care institutions around the world. At many institutions, this has resulted in efforts to prioritize cases with an attempt to balance the acuity of medical needs with available resources. Here, we provide a framework for institutions and governments to help adjudicate treatment allocations to patients with neuro-oncologic disease.","J Neurooncol","Ramakrishna, Rohan","Zadeh, Gelareh","Sheehan, Jason P","Aghi, Manish K","32274630"],"abstract":["The Coronavirus pandemic has created unprecedented strain on medical resources at health care institutions around the world. At many institutions, this has resulted in efforts to prioritize cases with an attempt to balance the acuity of medical needs with available resources. Here, we provide a framework for institutions and governments to help adjudicate treatment allocations to patients with neuro-oncologic disease."],"journal":"J Neurooncol","authors":["Ramakrishna, Rohan","Zadeh, Gelareh","Sheehan, Jason P","Aghi, Manish K"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32274630","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1007/s11060-020-03488-7","keywords":["acoustic neuroma","brain metastasis","covid19","coronavirus","endoscopic endonasal","glioblastoma","glioma","meningioma","neuro-oncology","neurosurgery","sars-cov-2","skull base"],"topics":["Prevention"],"weight":1,"_version_":1666138491726069761,"score":106.69879},{"pmid":32369601,"title":"Neuro-oncology Management During the COVID-19 Pandemic With a Focus on WHO Grade III and IV Gliomas.","text":["Neuro-oncology Management During the COVID-19 Pandemic With a Focus on WHO Grade III and IV Gliomas.","BACKGROUND: Because of the increased risk in cancer patients of developing complications caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), physicians have to balance the competing risks of the negative impact of the pandemic and the primary tumor. In this consensus statement, an international group of experts present mitigation strategies and treatment guidance for patients suffering from high grade gliomas (HGG) during the coronavirus disease 2019 (COVID-19) pandemic. METHOD / RESULTS: 16 international experts in the treatment of HGG contributed to this consensus-based practice recommendation including neuro-oncologists, neurosurgeons, radiation -oncologists and a medical physicist. Generally, treatment of neuro-oncological patients cannot be significantly delayed and initiating therapy should not be outweighed by COVID-19. We present detailed interdisciplinary treatment strategies for molecular subgroups in two pandemic scenarios, a scale-up phase and a crisis phase. CONCLUSION: This practice recommendation presents a pragmatic framework and consensus-based mitigation strategies for the treatment of HGG patients during the SARS-CoV-2 pandemic.","Neuro Oncol","Bernhardt, Denise","Wick, Wolfgang","Weiss, Stephanie E","Sahgal, Arjun","Lo, Simon S","Suh, John H","Chang, Eric L","Foote, Matthew","Perry, James","Meyer, Bernhard","Vajkoczy, Peter","Wen, Patrick Y","Straube, Christoph","Pigorsch, Steffi","Wilkens, Jan J","Combs, Stephanie E","32369601"],"abstract":["BACKGROUND: Because of the increased risk in cancer patients of developing complications caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), physicians have to balance the competing risks of the negative impact of the pandemic and the primary tumor. In this consensus statement, an international group of experts present mitigation strategies and treatment guidance for patients suffering from high grade gliomas (HGG) during the coronavirus disease 2019 (COVID-19) pandemic. METHOD / RESULTS: 16 international experts in the treatment of HGG contributed to this consensus-based practice recommendation including neuro-oncologists, neurosurgeons, radiation -oncologists and a medical physicist. Generally, treatment of neuro-oncological patients cannot be significantly delayed and initiating therapy should not be outweighed by COVID-19. We present detailed interdisciplinary treatment strategies for molecular subgroups in two pandemic scenarios, a scale-up phase and a crisis phase. CONCLUSION: This practice recommendation presents a pragmatic framework and consensus-based mitigation strategies for the treatment of HGG patients during the SARS-CoV-2 pandemic."],"journal":"Neuro Oncol","authors":["Bernhardt, Denise","Wick, Wolfgang","Weiss, Stephanie E","Sahgal, Arjun","Lo, Simon S","Suh, John H","Chang, Eric L","Foote, Matthew","Perry, James","Meyer, Bernhard","Vajkoczy, Peter","Wen, Patrick Y","Straube, Christoph","Pigorsch, Steffi","Wilkens, Jan J","Combs, Stephanie E"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32369601","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1093/neuonc/noaa113","keywords":["covid-19","sars-cov-2","glioblastoma","high-grade glioma","neuro-oncology"],"topics":["Prevention"],"weight":1,"_version_":1666138496143720450,"score":51.779255},{"pmid":32277236,"pmcid":"PMC7184330","title":"Urgent Considerations for the Neuro-oncologic Treatment of Patients with Gliomas During the COVID-19 Pandemic.","text":["Urgent Considerations for the Neuro-oncologic Treatment of Patients with Gliomas During the COVID-19 Pandemic.","The COVID-19 outbreak is posing unprecedented risks and challenges for all communities and healthcare systems, worldwide. There are unique considerations for many adult patients with gliomas who are vulnerable to the novel coronavirus due to older age and immunosuppression. As patients with terminal illnesses, they present ethical challenges for centers that may need to ration access to ventilator care due to insufficient critical care capacity. It is urgent for the neuro-oncology community to develop a pro-active and coordinated approach to the care of adults with gliomas in order to provide them with the best possible oncologic care while also reducing their risk of viral infection during times of potential healthcare system failure. In this article, we present an approach developed by an international multi-disciplinary group to optimize the care of adults with gliomas during this pandemic. We recommend measures to promote strict social distancing and minimize exposures for patients, address risk and benefit of all therapeutic interventions, pro-actively develop end of life plans, educate patients and caregivers and ensure the health of the multi-disciplinary neuro-oncology workforce. This pandemic is already changing neuro-oncologic care delivery around the globe. It is important to highlight opportunities to maximize the benefit and minimize the risk of glioma management during this pandemic and potentially, in the future.","Neuro Oncol","Mohile, Nimish A","Blakeley, Jaishri O","Gatson, Na Tosha N","Hottinger, Andreas F","Lassman, Andrew B","Ney, Douglas E","Olar, Adriana","Schiff, David","Shih, Helen A","Strowd, Roy","van den Bent, Martin J","Ziu, Mateo","32277236"],"abstract":["The COVID-19 outbreak is posing unprecedented risks and challenges for all communities and healthcare systems, worldwide. There are unique considerations for many adult patients with gliomas who are vulnerable to the novel coronavirus due to older age and immunosuppression. As patients with terminal illnesses, they present ethical challenges for centers that may need to ration access to ventilator care due to insufficient critical care capacity. It is urgent for the neuro-oncology community to develop a pro-active and coordinated approach to the care of adults with gliomas in order to provide them with the best possible oncologic care while also reducing their risk of viral infection during times of potential healthcare system failure. In this article, we present an approach developed by an international multi-disciplinary group to optimize the care of adults with gliomas during this pandemic. We recommend measures to promote strict social distancing and minimize exposures for patients, address risk and benefit of all therapeutic interventions, pro-actively develop end of life plans, educate patients and caregivers and ensure the health of the multi-disciplinary neuro-oncology workforce. This pandemic is already changing neuro-oncologic care delivery around the globe. It is important to highlight opportunities to maximize the benefit and minimize the risk of glioma management during this pandemic and potentially, in the future."],"journal":"Neuro Oncol","authors":["Mohile, Nimish A","Blakeley, Jaishri O","Gatson, Na Tosha N","Hottinger, Andreas F","Lassman, Andrew B","Ney, Douglas E","Olar, Adriana","Schiff, David","Shih, Helen A","Strowd, Roy","van den Bent, Martin J","Ziu, Mateo"],"date":"2020-04-12T11:00:00Z","year":2020,"_id":"32277236","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1093/neuonc/noaa090","keywords":["adult glioma","covid-19","pandemic"],"topics":["Prevention"],"weight":1,"_version_":1666138491641135104,"score":48.53376},{"pmid":32311303,"title":"Surgical Considerations for an Awake Tracheotomy During the COVID-19 Pandemic.","text":["Surgical Considerations for an Awake Tracheotomy During the COVID-19 Pandemic.","Background: The current global COVID-19 pandemic is caused by the novel coronavirus Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2). Given that SARS-CoV-2 is highly transmissible, surgical societies have recommended that procedures with a high risk of aerosolization be avoided or delayed. However, some high-risk procedures, such as those related to head and neck malignancies, cannot always be delayed. Care must be taken during aerosol-generating procedures to minimize viral transmission as much as possible. Preoperative testing for COVID-19, limited operating room personnel, adequate personal protective equipment, and surgical technique are factors to consider for high-risk procedures. Methods: This article presents the case of an awake tracheotomy performed for a transglottic mass causing airway obstruction. Results: With detailed planning and specific techniques, the amount of aerosolization was reduced, and the procedure was performed as safely as possible. Conclusion: This case provides a template for future aerosol-generating procedures during respiratory pandemics.","J Laparoendosc Adv Surg Tech A","Crossley, Jason","Clark, Christine","Brody, Fredrick","Maxwell, Jessica H","32311303"],"abstract":["Background: The current global COVID-19 pandemic is caused by the novel coronavirus Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2). Given that SARS-CoV-2 is highly transmissible, surgical societies have recommended that procedures with a high risk of aerosolization be avoided or delayed. However, some high-risk procedures, such as those related to head and neck malignancies, cannot always be delayed. Care must be taken during aerosol-generating procedures to minimize viral transmission as much as possible. Preoperative testing for COVID-19, limited operating room personnel, adequate personal protective equipment, and surgical technique are factors to consider for high-risk procedures. Methods: This article presents the case of an awake tracheotomy performed for a transglottic mass causing airway obstruction. Results: With detailed planning and specific techniques, the amount of aerosolization was reduced, and the procedure was performed as safely as possible. Conclusion: This case provides a template for future aerosol-generating procedures during respiratory pandemics."],"journal":"J Laparoendosc Adv Surg Tech A","authors":["Crossley, Jason","Clark, Christine","Brody, Fredrick","Maxwell, Jessica H"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32311303","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1089/lap.2020.0239","keywords":["covid-19","pandemic","tracheotomy"],"topics":["Prevention"],"weight":1,"_version_":1666138491166130179,"score":45.909847},{"pmid":32360732,"pmcid":"PMC7192077","title":"The Management Of Neurosurgical Patients During The Covid-19 Pandemic.","text":["The Management Of Neurosurgical Patients During The Covid-19 Pandemic.","The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is, to date, the major challenge for healthcare systems worldwide. Hospital represents one of main vector amplifying the spread of the disease among both patients and healthcare professionals. Adequate department organization is pivotal to reduce hazards while still ensuring the highest quality of care. In this document we aim to share the recent experience of a Neurosurgery department located in one of the first and largest coronavirus disease 2019 (COVID-19) pandemic epicenters. A review of the available literature was also performed. Case selection, operating room and postoperative management of neurosurgical patients were discussed. COVID-19 pandemic has upset healthcare organizations, requiring a deep reorganization in many respects. An adequate management protocol can reduce hospital viral spread, improving safety both for patients and healthcare professionals.","World Neurosurg","Spina, Alfio","Boari, Nicola","Gagliardi, Filippo","Bailo, Michele","Calvanese, Francesco","Mortini, Pietro","32360732"],"abstract":["The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is, to date, the major challenge for healthcare systems worldwide. Hospital represents one of main vector amplifying the spread of the disease among both patients and healthcare professionals. Adequate department organization is pivotal to reduce hazards while still ensuring the highest quality of care. In this document we aim to share the recent experience of a Neurosurgery department located in one of the first and largest coronavirus disease 2019 (COVID-19) pandemic epicenters. A review of the available literature was also performed. Case selection, operating room and postoperative management of neurosurgical patients were discussed. COVID-19 pandemic has upset healthcare organizations, requiring a deep reorganization in many respects. An adequate management protocol can reduce hospital viral spread, improving safety both for patients and healthcare professionals."],"journal":"World Neurosurg","authors":["Spina, Alfio","Boari, Nicola","Gagliardi, Filippo","Bailo, Michele","Calvanese, Francesco","Mortini, Pietro"],"date":"2020-05-04T11:00:00Z","year":2020,"_id":"32360732","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.wneu.2020.04.161","keywords":["covid-19","coronavirus","neurosurgery","sars-cov-2"],"locations":["Neurosurgery"],"topics":["Prevention"],"weight":1,"_version_":1666138495491506176,"score":45.513195}]}